Is Utah Medical Products Inc (UTMD) overvalued? · P/E 15, rev $9.2M
Utah Medical Products Inc (UTMD) is a medical instruments & supplies company listed on US.
This page asks whether Utah Medical Products Inc (UTMD) looks expensive on cached numbers — not a short thesis.
Latest reported UTMD revenue for 2024-12-31 was $9.2M. Net income was $2.9M. Revenue was down 8.5% from 2024-09-30 to 2024-12-31. UTMD currently screens at market cap $189.8M and trailing P/E 15.4.
UTMD currently screens at market cap $189.8M and trailing P/E 15.4. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next UTMD 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the UTMD stock page for the full model, not this heading.
Not investment advice.